Tyndall Capital Partners L P, 10% Owner at Onconova Therapeutics, Inc. (ONTX), sold 5,415 shares at $2.75 ($15K) on 2019-09-05, disclosed to the SEC on 2019-09-09.
Open-market sale of $15k ONTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.75 | 400 | $1K | 7.3% |
| 2 | $2.78 | 5,015 | $14K | 92.7% |
| Total | $2.78 avg | 5,415 | $15K | 100% |
| Filing → |
| ONTX | SELL | 2019-09-20 | $210K | — | Filing → |
| ONTX | SELL | 2019-09-13 | $3K | — | Filing → |
| ONTX | SELL | 2019-09-11 | $1K | — | Filing → |